Novadip Biosciences announces EUR 19 million Series B financing backed by international investors
28 oct. 2021 07h00 HE
|
Novadip Biosciences
Novadip Biosciences announces EUR 19 million Series B financing backed by international investors New investment to fuel continued growth of 3M³ platform for the development of products in tissue...
Novadip Biosciences announces EUR 19 million Series B financing backed by international investors
28 oct. 2021 01h00 HE
|
Novadip Biosciences
Novadip Biosciences announces EUR 19 million Series B financing backed by international investors New investment to fuel continued growth of 3M³ platform for the development of products in tissue...
Novadip Biosciences reports positive data from phase I study of NVD-001 for spinal fusion
15 juin 2021 01h00 HE
|
Novadip Biosciences
Novadip Biosciences reports positive data from phase I study of NVD-001 for spinal fusion Primary endpoint met, study validates autologous cell therapy 3M³ platform for bone regeneration...
Novadip Biosciences receives IND approval from the FDA for regenerative bone product NVD-003
04 mars 2021 07h00 HE
|
Novadip Biosciences
Novadip Biosciences receives IND approval from the FDA for regenerative bone product NVD-003 - Authorization to start clinical trial in the US granted for rare paediatric bone disease ...
Novadip Biosciences receives IND approval from the FDA for regenerative bone product NVD-003
04 mars 2021 02h00 HE
|
Novadip Biosciences
Novadip Biosciences receives IND approval from the FDA for regenerative bone product NVD-003 - Authorization to start clinical trial in the US granted for rare paediatric bone disease ...
Novadip Biosciences Receives Rare Paediatric Disease Priority Review and Orphan Disease Designation
23 déc. 2020 06h00 HE
|
Novadip Biosciences
Novadip Biosciences Receives Rare Paediatric Disease Priority Review and Orphan Disease Designation Dual designations granted for NVD-003 for the Treatment of Congenital Pseudarthrosis of the Tibia...
Novadip Biosciences to Present at the LifeSci Partners Summer Symposium
29 juil. 2020 07h00 HE
|
Novadip Biosciences
Novadip Biosciences to Present at the LifeSci Partners Summer Symposium Mont-Saint Guibert, Belgium, 29 July, 2020: Novadip Biosciences (“Novadip” or “the Company”), a clinical-stage...
Novadip Biosciences to Present at the LifeSci Partners Summer Symposium
29 juil. 2020 02h28 HE
|
Novadip Biosciences
Novadip Biosciences to Present at the LifeSci Partners Summer Symposium Mont-Saint Guibert, Belgium, 29 July, 2020: Novadip Biosciences (“Novadip” or “the Company”), a clinical-stage...
Novadip Biosciences to unveil its 3M3 Platform at BIO Digital 2020
04 juin 2020 07h00 HE
|
Novadip Biosciences
Novadip Biosciences to unveil its 3M3 Platform at BIO Digital 2020 -Unique 3M3 tissue regeneration technology platform generates multiple product candidates: autologous, off-the-shelf and...
Novadip Biosciences to unveil its 3M3 Platform at BIO Digital 2020
04 juin 2020 02h00 HE
|
Novadip Biosciences
Novadip Biosciences to unveil its 3M3 Platform at BIO Digital 2020 -Unique 3M3 tissue regeneration technology platform generates multiple product candidates: autologous, off-the-shelf and...